The Infant Immune System: Implications for Vaccines and Response to Infections (R01)

Post Date

March 11th 2011

Application Due Date

July 8th 2011

Funding Opportunity Number

RFA-AI-11-010

CFDA Number(s)

93.855
93.856

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.

Funding

• Estimated Total Funding:

  $2300000

• Award Range:

  $None - $300000

Grant Description

The National Institute of Allergy and Infectious Diseases (NIAID) invites applications from institutions and organizations to define mechanisms for establishing and maintaining immunity in infants (0-12 months of age) after infection with or vaccination against infectious agents that cause diseases in this vulnerable population (i.e. childhood infections). The goal of this FOA is to improve our understanding of immune defense mechanisms in infants in order to improve their immune status in the long term. In order to encourage highly innovative studies, extensive preliminary data or a proven track record in neonatal immunology is not required. Research with human cells and tissues is encouraged, although studies using appropriately justified infant animal models are acceptable.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-11-010.html